taurine

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

athletic performance

[Insufficient Evidence]

Dose: 1-6 g PO qd; Alt: 50 mg/kg/dose PO x1 given 90-120min before performance; 40 mg/kg/dose PO qd; 1-6 g PO x1 given 60min before performance

CHF

[Possibly Effective]

Dose: 0.5-6 g/day PO divided qd-tid

cystic fibrosis

[Insufficient Evidence]

Dose: 30-40 mg/kg/dose PO qd; Info: for use in peds patients

delirium

[Insufficient Evidence]

Dose: 2 g PO qd

diabetes mellitus, type 1

[Insufficient Evidence]

Dose: 1.5 g PO qd

diabetes mellitus, type 2

[Insufficient Evidence]

Dose: 1 g PO tid; Alt: 2.5 g/day PO divided bid with exercise training 3x/wk; 1-3 g PO qd

erectile dysfunction

[Insufficient Evidence]

Dose: 50 mg PO q24h; Info: used with or without tadalafil

exercise-induced muscle soreness

[Insufficient Evidence]

Dose: 2 g PO tid with meals

fatigue

[Insufficient Evidence]

Dose: 1 g PO x1 in 500 mL energy drink

H. pylori infection

[Insufficient Evidence]

Dose: 500 mg PO bid; Info: used with standard tx

hepatitis

[Possibly Effective]

Dose: 1.5-4 g PO qd

HTN

[Insufficient Evidence]

Dose: 0.5-6 g PO qd

hyperlipidemia

[Insufficient Evidence]

Dose: 0.5-6 g PO qd; Alt: 0.5 g PO bid with exercise training 3x/wk

iron deficiency anemia

[Insufficient Evidence]

Dose: 1 g PO qd; Info: used with ferrous sulfate

muscular dystrophy

[Insufficient Evidence]

Dose: 100-150 mg/kg/dose PO qd

nausea/vomiting, chemo-related

[Insufficient Evidence]

Dose: 1 g PO bid; Start: 6h after chemo

nephrotoxicity, chemo-induced

[Insufficient Evidence]

Dose: 1 g PO bid

physical performance

[Insufficient Evidence]

Dose: 1.5 g PO qd with exercise training; Info: for use in elderly patients

postop recovery

[Insufficient Evidence]

Dose: 6 g PO qd

psychosis

[Insufficient Evidence]

Dose: 4 g PO qd; Info: used with antipsychotic tx

sleep deprivation

[Insufficient Evidence]

Dose: 2 g PO x1; Info: used with caffeine

Tourette syndrome, peds patients

[Insufficient Evidence]

Dose: 0.8 g PO tid in patients 6-8 yo; 1.2 g PO tid in patients 9-13 yo; 1.6 g PO tid in patients 14-16 yo; Info: used with tiapride doses <300 mg

traumatic brain injury

[Insufficient Evidence]

Dose: 30 mg/kg/day PO divided bid; Max: 3000 mg/day